GemVax's Largest Shareholder Gem&Company Pledges 5.23M Shares, Risking Ownership Drop from 12.32% to 0.51%, Dilution and Control Change Concerns
Gem&Company, the largest shareholder of GemVax, has pledged 5,229,974 of its 5,456,126 shares across 13 loan contracts, risking a stake drop from 12.32% to 0.51% if all pledges are executed.
Total secured debt amounts to 49.09 billion KRW, while Gem&Company's financial health is critically weak with liabilities of 87.99 billion KRW, negative equity of 75.212 billion KRW, and a net loss of 13.62 billion KRW as of fiscal 2025.
Creditors include Hana Bank, savings banks, private companies, and individuals; in case of default, massive share liquidation could pressure GemVax's stock price.
The pledged loans are solely for Gem&Company's operating funds, unrelated to GemVax's own capital needs or expansion, offering no direct benefit to shareholders.
[AI Summary]The largest shareholder's pledge of 5.23 million shares represents 11.81% of GemVax's outstanding shares, creating severe dilution risk. Gem&Company's deep insolvency and diverse creditor base raise the likelihood of pledge execution, threatening control stability and stock price.
KOSDAQ Filing Information
[Correction of Description] Execution of Stock Pledge Agreement Involving Change of Largest Shareholder